Last Price$228.1(1.8%)
Market Cap$16.9B
34.6%
Industry median - 52.5%
5Y Historical average - 37.7%
20.2%
Industry median - 4.9%
5Y Historical average - 22.1%
9.6%
Industry median - 6.9%
5Y Historical average - 13.1%
56.1%
Industry median - 41.1%
5Y Historical average - 70.1%
WST Profitability Rating
WST Profitability rating
6.8
WST Profitability rating performance
WST Profitability Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with WST Profitability
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Profitability rating | Gross Profit margin (LTM) | EBIT margin (LTM) | EBITDA margin (LTM) | Net Income margin (LTM) | FCF margin (LTM) | Earnings quality (FCF to Net Income) |
$16.9B | 6.8 | 34.6% | 19.9% | 25.6% | 17.0% | 9.6% | 56.1% | |
$207.3B | 7.5 | 67.5% | 28.1% | 33.1% | 27.8% | 12.9% | 46.2% | |
$66.3B | 7.2 | 59.4% | 12.9% | 17.8% | 8.5% | 14.2% | 170.0% | |
$46.6B | 7.9 | 55.6% | 14.2% | 20.5% | 10.3% | 6.1% | 129.1% | |
$34.6B | 8.9 | 57.9% | 31.7% | 33.6% | 25.3% | 28.2% | 111.2% | |
$18.6B | 7.0 | 62.8% | 18.1% | 25.9% | 10.1% | 7.4% | 73.4% | |
$17.9B | 4.3 | 37.1% | (1.1%) | 7.4% | (5.0%) | 4.4% | (91.9%) | |
$14.7B | 8.7 | 56.2% | 23.9% | 30.2% | 18.4% | 28.1% | 152.6% | |
$10.4B | 4.0 | 48.0% | (12.7%) | (9.6%) | (14.6%) | 6.9% | (47.7%) | |
$9,757.8M | 7.3 | 48.7% | 14.1% | 21.1% | 10.5% | 9.7% | 93.3% | |
$8,979.7M | 5.8 | 46.9% | (0.8%) | 14.2% | (3.4%) | 21.3% | (633.3%) |
FAQ
What is the West Pharmaceutical Services, Inc. (WST) gross profit margin?
The West Pharmaceutical Services, Inc. (WST) gross profit margin is 34.6%, compared to the industry median of 52.5% and the 5-year historical average of 37.7%.
What is the West Pharmaceutical Services, Inc. (WST) operating income margin?
The West Pharmaceutical Services, Inc. (WST) operating income margin is 20.2%, compared to the industry median of 4.9%) and the 5-year historical average of 22.1%.
What is the West Pharmaceutical Services, Inc. (WST) Free Cash Flow (FCF) margin?
The West Pharmaceutical Services, Inc. (WST) Free Cash Flow margin is 9.6%, compared to the industry median of 6.9% and the 5-year historical average of 13.1%.
What is the West Pharmaceutical Services, Inc. (WST) earnings quality?
The West Pharmaceutical Services, Inc. (WST) earnings quality is 56.1%, compared to the industry median of 41.1% and the 5-year historical average of 70.1%.